3D1015 / 3DMed - LARVOL DELTA

SUCCESSFULLY ADMINISTERS FIRST DOSE IN HUMAN FOR NOVEL RADIOACTIVE DRUG CONJUGATE 3D1015 (HKEXnews) - "The study aims to evaluate the safety and preliminary efficacy of 3D1015 in patients with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC)."

Trial status • Castration-Resistant Prostate Cancer